Auxiliary label

Last updated
Examples of auxiliary labels placed on prescriptions. Auxiliary Labels.jpg
Examples of auxiliary labels placed on prescriptions.

An auxiliary label (also called cautionary and advisory label or prescription drug warning label) is a label added on to a dispensed medication package by a pharmacist in addition to the usual prescription label. These labels are intended to provide supplementary information regarding the safe administration, use, and storage of the medication. [1] Auxiliary labels provide information which can augment but not replace verbal counselling from a pharmacist. [2]

Contents

History

Auxiliary labels became popular during the second half of the nineteenth century. [3]

In 2013, the first recommendations for auxiliary label usage in the United States were published as USP Chapter <17>. [4] This included a recommendation to limit the use of auxiliary labels to evidence-based labels with critical information, and without pictures unless evidence shows increased efficacy when a picture is used. It is further recommended that labels are placed in a manner obvious to the patient without having to turn or rotate the package. [4]

Contents

Auxiliary label stating the medication must be swallowed whole, without crushing or chewing. Swallow whole auxiliary label.jpg
Auxiliary label stating the medication must be swallowed whole, without crushing or chewing.
Auxiliary labels stating "take with food or milk" and "do not take with aspirin" USMC-100209-M-1998T-001 (cropped).jpg
Auxiliary labels stating "take with food or milk" and "do not take with aspirin"

Auxiliary labels are generally small stickers consisting of a pictogram and one or more lines of text intended to enhance patient knowledge. They generally contain information not contained in the "directions" on the prescription label itself. This can include supplementary directions for administration, whether the medication can be chewed, crushed, or cut, and information on side effects or drug/food interactions. [5] [6] All auxiliary labels contain information important to proper medication adherence, or to avoid adverse drug reactions. [7] There is not one guideline for how to best formulate auxiliary labels on a prescription, but the label should be as simple as possible and written in plain language. [6]

A 2016 study found that many patients consider side effects to be important information on a prescription package and that auxiliary labels are a good tool to provide this information on the packaging itself (as opposed to a separate information sheet/handout). [8] The same study found that patients associated the use of red as a highlight color with information regarding warnings, allergies, or side effects. [8]

Some auxiliary labels are used not to add additional information to the package, but to provide a pictorial representation of the instructions for use. [9] Picture representations of directions can be useful for patients with low literacy, or who have trouble reading and comprehending text instructions due to age, eyesight, or other factors. [9]

Usage

Deciding what auxiliary labels are suitable for a particular prescription requires knowledge of the drug's classification, interactions, and side effects. [10] One study of auxiliary label usage found that about 80% of prescriptions require at least one auxiliary label to provide important information aside from the directions for use. [6] The most common auxiliary labels on prescriptions include "May cause drowsiness" and "alcohol may intensify the effect of this medication". [6]

Auxiliary labels placed on a prescription vial may be placed vertically, horizontally, or on the vial cap ("interactive placement"). Placement of the label in an interactive manner where the patient must interact with it to open the vial is more likely to be noticed and comprehended by the patient. [4] Both horizontal and interactive placement are superior to vertical placement, which may be due to the need to rotate the vial to read the information on the label. [4] One study in 2007 found that 82% of prescriptions had auxiliary labels placed vertically, requiring the bottle to be tilted to read the text. The same study found a wide variation in coloring used on auxiliary labels from different pharmacies, and that between 8-25% of prescriptions filled had no warning labels at all. [11]

The use of auxiliary labels does not substitute for pharmacist consultation about medications, nor for any supplemental medication guides or handouts recommended or required to be distributed with a drug. Auxiliary labels should only be used to remind or enhance instructions for use or warnings that have already been given by the pharmacist or doctor to the patient verbally. [12]

Effectiveness

Auxiliary labels can commonly be misinterpreted, especially when multi-step or multi-part instructions are present on one label. [7] Misinterpretation of auxiliary labels can occur when patients are unable to understand the wording of the label, and thus assume an instruction based on the pictogram or color of the label. [7] In addition to misinterpretation, some studies have found that most patients ignore auxiliary labels on prescriptions completely, especially those with low health literacy. [5] This may be due in part to the belief that information presented on the bottle is not important, or due to the manner in which the labels are affixed to the vial. [5] When auxiliary labels are used as a reminder to the patient of important information, failure to understand and follow the instructions from auxiliary labels can result in treatment failure or adverse effects. [5] The effectiveness of auxiliary labels can vary greatly between different label formats and specific text, with a 2006 survey finding that one common multi-step, complex label ("Do not take dairy products, antacids, or iron preparations within 1 hour of this medication") was interpreted correctly only 7.6% of the time. [7]

The overall effectiveness of auxiliary labels depends on the number of labels affixed, the design of the label, and their positioning on the medication package or vial. [13] Simplifying the content and number of auxiliary labels can improve patient comprehension. [14] In the United States, many labels are commonly only stocked in English, which can decrease the chance of understanding in areas with significant non-English speaking populations. Only one third of auxiliary labels in the United States are available in languages other than English. [7]

Common elements considered to increase the chance of effectiveness of an auxiliary label include a single-step instruction, using easy-to-read text (for example, low Lexile score), use of clear, simple icons (if present), use of color to represent severity, and clarity of the instruction being represented. [15] Font size and style, including boldface or capitalization patterns, can also impact the effectiveness of an auxiliary label. [15] The effectiveness of auxiliary labels is also increased when pharmacists explicitly instruct patients on their presence on the package, and explain the importance of each of the warnings being presented using the auxiliary labels. [12] It has also been recommended that people with low health literacy and low literacy in general be consulted during the design process for auxiliary labels to improve the chance for comprehension and effectiveness. [7]

Related Research Articles

<span class="mw-page-title-main">Over-the-counter drug</span> Medication available without a prescription

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription from a healthcare professional, as opposed to prescription drugs, which may be supplied only to consumers possessing a valid prescription. In many countries, OTC drugs are selected by a regulatory agency to ensure that they contain ingredients that are safe and effective when used without a physician's care. OTC drugs are usually regulated according to their active pharmaceutical ingredient (API) rather than final products. By regulating APIs instead of specific drug formulations, governments allow manufacturers the freedom to formulate ingredients, or combinations of ingredients, into proprietary mixtures.

<span class="mw-page-title-main">Pharmacist</span> Healthcare professional

A pharmacist, also known as a chemist or a druggist, is a healthcare professional who specializes in the preparation, dispensing, and management of medications to ensure safe and effective use, while also providing medication counseling and guidance to patients and healthcare providers. Also, pharmacists often serve as primary care providers in the community, and may offer other services such as health screenings and immunizations.

<span class="mw-page-title-main">Pharmacy</span> Clinical health science

Pharmacy is the science and practice of discovering, producing, preparing, dispensing, reviewing and monitoring medications, aiming to ensure the safe, effective, and affordable use of medicines. It is a miscellaneous science as it links health sciences with pharmaceutical sciences and natural sciences. The professional practice is becoming more clinically oriented as most of the drugs are now manufactured by pharmaceutical industries. Based on the setting, pharmacy practice is either classified as community or institutional pharmacy. Providing direct patient care in the community of institutional pharmacies is considered clinical pharmacy.

<span class="mw-page-title-main">Medical prescription</span> Health-care communication from a physician to a pharmacist

A prescription, often abbreviated or Rx, is a formal communication from a physician or other registered healthcare professional to a pharmacist, authorizing them to dispense a specific prescription drug for a specific patient. Historically, it was a physician's instruction to an apothecary listing the materials to be compounded into a treatment—the symbol ℞ comes from the first word of a medieval prescription, Latin recipere, that gave the list of the materials to be compounded.

<span class="mw-page-title-main">Prescription drug</span> Medication legally requiring a medical prescription before it can be dispensed

A prescription drug is a pharmaceutical drug that is permitted to be dispensed only to those with a medical prescription. In contrast, over-the-counter drugs can be obtained without a prescription. The reason for this difference in substance control is the potential scope of misuse, from drug abuse to practicing medicine without a license and without sufficient education. Different jurisdictions have different definitions of what constitutes a prescription drug.

In medicine, patient compliance describes the degree to which a patient correctly follows medical advice. Most commonly, it refers to medication or drug compliance, but it can also apply to other situations such as medical device use, self care, self-directed exercises, or therapy sessions. Both patient and health-care provider affect compliance, and a positive physician-patient relationship is the most important factor in improving compliance. Access to care plays a role in patient adherence, whereby greater wait times to access care contributing to greater absenteeism. The cost of prescription medication also plays a major role.

IntercomPlus is the Walgreen Company's proprietary pharmacy computer system. It was founded as Intercom in 1981, and was the first large scale retail pharmacy computer system. It relies on VSAT satellite access and/or broadband connections to link the over 8,000 Walgreens retail, mail service, and specialty pharmacies. Through its usage, Intercom made Walgreens the largest private user of satellite transmission data in the world, second only to the U.S. Government. The design of the system enables seamless store-to-store prescription filling, making filling a refill at a location other than where it was filled originally essentially no different from filling it again at the original location.

Combined drug intoxication (CDI), or multiple drug intake (MDI), is a cause of death by drug overdose from poly drug use, often implicated in polysubstance dependence.

<span class="mw-page-title-main">Clinical pharmacy</span> Branch of pharmacy for direct provision

Clinical pharmacy is the branch of pharmacy in which clinical pharmacists provide direct patient care that optimizes the use of medication and promotes health, wellness, and disease prevention. Clinical pharmacists care for patients in all health care settings but the clinical pharmacy movement initially began inside hospitals and clinics. Clinical pharmacists often work in collaboration with physicians, physician assistants, nurse practitioners, and other healthcare professionals. Clinical pharmacists can enter into a formal collaborative practice agreement with another healthcare provider, generally one or more physicians, that allows pharmacists to prescribe medications and order laboratory tests.

<span class="mw-page-title-main">Pharmacy (shop)</span> Shop which provides pharmaceutical drugs

A pharmacy is a retail shop which provides pharmaceutical drugs, among other products. At the pharmacy, a pharmacist oversees the fulfillment of medical prescriptions and is available to counsel patients about prescription and over-the-counter drugs or about health problems and wellness issues. A typical pharmacy would be in the commercial area of a community.

Medication therapy management, generally called medicine use review in the United Kingdom, is a service provided typically by pharmacists, medical affairs, and RWE scientists that aims to improve outcomes by helping people to better understand their health conditions and the medications used to manage them. This includes providing education on the disease state and medications used to treat the disease state, ensuring that medicines are taken correctly, reducing waste due to unused medicines, looking for any side effects, and providing education on how to manage any side effects. The process that can be broken down into five steps: medication therapy review, personal medication record, medication-related action plan, intervention and or referral, and documentation and follow-up.

<span class="mw-page-title-main">Remote dispensing</span>

Remote dispensing is used in health care environments to describe the use of automated systems to dispense prescription medications without an on-site pharmacist. This practice is most common in long-term care facilities and correctional institutions that do not find it practical to operate a full-service in-house pharmacy.

Automatic Generic Substitution is a proposal by the Department of Health (DH) whereby in January 2010 pharmacists could be obliged to substitute a generic version of a medication even if the prescriber had written the prescription for a specific brand, as part of a new deal on drug pricing.

Pharmacy automation involves the mechanical processes of handling and distributing medications. Any pharmacy task may be involved, including counting small objects ; measuring and mixing powders and liquids for compounding; tracking and updating customer information in databases ; and inventory management. This article focuses on the changes that have taken place in the local, or community pharmacy since the 1960s.

<span class="mw-page-title-main">Drug packaging</span> Packaging for pharmaceutical preparations

Pharmaceutical packaging is the packages and the packaging processes for pharmaceutical preparations. It involves all of the operations from production through drug distribution channels to the end consumer.

There are approximately 88,000 pharmacies in the United States. Over half are located within drug stores, grocery stores, hospitals, department stores, medical clinics, surgery clinics, universities, nursing homes, prisons, and other facilities. The remaining pharmacies are considered to be independent or privately owned. The top 25 pharmacy chain stores represent about 38,000 pharmacy locations in the U.S. and employ about 149,000 on-staff pharmacists. California has 8,015 pharmacies, the most of any state. Texas, Florida, New York, and Pennsylvania round out the top five states for pharmacy locations. Nationwide, the number of community pharmacies increased by 6.3% between 2007-2015, and the number of pharmacies per 10,000 people (2.11) did not change. However, the number of pharmacies per-capita varies substantially across counties, ranging from 0 to 13.6 per- 10,000 people in 2015.

<span class="mw-page-title-main">Telepharmacy</span> Pharmacy care by telecommunication

Telepharmacy is the delivery of pharmaceutical care via telecommunications to patients in locations where they may not have direct contact with a pharmacist. It is an instance of the wider phenomenon of telemedicine, as implemented in the field of pharmacy. Telepharmacy services include drug therapy monitoring, patient counseling, prior authorization and refill authorization for prescription drugs, and monitoring of formulary compliance with the aid of teleconferencing or videoconferencing. Remote dispensing of medications by automated packaging and labeling systems can also be thought of as an instance of telepharmacy. Telepharmacy services can be delivered at retail pharmacy sites or through hospitals, nursing homes, or other medical care facilities.

Drug recycling, also referred to as medication redispensing or medication re-use, is the idea that health care organizations or patients with unused drugs can transfer them in a safe and appropriate way to another patient in need. The purpose of such a program is reducing medication waste, thereby saving healthcare costs, enlarging medications’ availability and alleviating the environmental burden of medication.

<span class="mw-page-title-main">Drug labelling</span>

Drug labelling is also referred to as prescription labelling, is a written, printed or graphic matter upon any drugs or any of its container, or accompanying such a drug. Drug labels seek to identify drug contents and to state specific instructions or warnings for administration, storage and disposal. Since 1800s, legislation has been advocated to stipulate the formats of drug labelling due to the demand for an equitable trading platform, the need of identification of toxins and the awareness of public health. Variations in healthcare system, drug incidents and commercial utilization may attribute to different regional or national drug label requirements. Despite the advancement in drug labelling, medication errors are partly associated with undesirable drug label formatting.

ScripTalk is an audible medication label technology designed to give access to individuals who are blind, visually impaired, or print impaired. It consists of a device and a microchip attached to the bottom of a prescription drug bottle. The label information is encoded on a Radio-frequency identification (RFID) electronic label (microchip) using the ScriptAbility software by a pharmacist and placed on the prescription package. ScripTalk prescription labels were introduced in the early 2000s. As of 2020, the technology was applied through the United States and Canada.

References

  1. "The Pharmaceutics and Compounding Laboratory". pharmlabs.unc.edu. Archived from the original on 2017-05-16. Retrieved 2016-04-18.
  2. "Guiding Principles for Assigning Auxiliary Labels for Outpatient Medications at BCCA" (PDF). BC Cancer Agency. Archived from the original (PDF) on 28 April 2016. Retrieved 18 April 2016.
  3. Griffenhagen, George; Bogard, Mary (1999). History of drug containers and their labels. Madison, Wis.: American Inst. of the History of Pharmacy. p. 35. ISBN   0931292263.
  4. 1 2 3 4 Lee, Jiyon; Ladoni, Moslem; Richardson, James; Sundar, Raghav P.; Bix, Laura (30 June 2019). "Investigating the efficacy of an interactive warning for use in labeling strategies used by us pharmacies". Pharmacy Practice. 17 (2): 1463. doi: 10.18549/PharmPract.2019.2.1463 . PMC   6594438 . PMID   31275502.
  5. 1 2 3 4 Davis, Terry C.; Wolf, Michael S.; Bass, Pat F.; Thompson, Jason A.; Tilson, Hugh H.; Neuberger, Marolee; Parker, Ruth M. (19 December 2006). "Literacy and Misunderstanding Prescription Drug Labels". Annals of Internal Medicine. 145 (12): 887–894. doi:10.7326/0003-4819-145-12-200612190-00144. PMID   17135578. S2CID   3472412.
  6. 1 2 3 4 Borgsteede, Sander D.; Heringa, Mette (August 2019). "Nature and frequency of dosing instructions on prescription labels in primary care". Pharmacoepidemiology and Drug Safety. 28 (8): 1060–1066. doi:10.1002/pds.4796. PMID   31134701. S2CID   167221843.
  7. 1 2 3 4 5 6 Davis, Terry C.; Wolf, Michael S.; Bass, Pat F.; Middlebrooks, Mark; Kennen, Estela; Baker, David W.; Bennett, Charles L.; Durazo-Arvizu, Ramon; Bocchini, Anna; Savory, Stephanie; Parker, Ruth M. (August 2006). "Low literacy impairs comprehension of prescription drug warning labels". Journal of General Internal Medicine. 21 (8): 847–851. doi:10.1111/j.1525-1497.2006.00529.x. PMC   1831578 . PMID   16881945.
  8. 1 2 Kebodeaux, Clark D.; Peters, Golden L.; Kindermann, Heather A.; Hurd, Peter D.; Berry, Tricia M. (May 2016). "Patient-perceived content and formatting expectations for prescription container labeling". Journal of the American Pharmacists Association. 56 (3): 242–247.e1. doi:10.1016/j.japh.2016.01.007. PMID   27067553.
  9. 1 2 Katz, Marra G.; Kripalani, Sunil; Weiss, Barry D. (1 December 2006). "Use of pictorial aids in medication instructions: A review of the literature". American Journal of Health-System Pharmacy. 63 (23): 2391–2397. doi:10.2146/ajhp060162. PMID   17106013.
  10. Hopper, Teresa (2012). Mosby's pharmacy technician : principles and practice (3rd ed.). St. Louis, Mo.: Elsevier Saunders. p. 217. ISBN   978-1437706703.
  11. Shrank, William H. (10 September 2007). "The Variability and Quality of Medication Container Labels". Archives of Internal Medicine. 167 (16): 1760–5. doi: 10.1001/archinte.167.16.1760 . PMID   17846395.
  12. 1 2 Wolf, Michael S. (11 January 2010). "Improving Prescription Drug Warnings to Promote Patient Comprehension". Archives of Internal Medicine. 170 (1): 50–6. doi: 10.1001/archinternmed.2009.454 . PMC   3845799 . PMID   20065199.
  13. "Rationalizing the use of Auxiliary Labels for oral oncology drugs" (PDF) (Conference poster). BC Cancer Agency. Retrieved 18 April 2016.
  14. Locke, Michelle R.; Shiyanbola, Olayinka O.; Gripentrog, Elizabeth (May 2014). "Improving prescription auxiliary labels to increase patient understanding". Journal of the American Pharmacists Association. 54 (3): 267–274. doi:10.1331/JAPhA.2014.13163. PMID   24816353.
  15. 1 2 Wolf, Michael S.; Davis, Terry C.; Tilson, Hugh H.; Bass, Pat F.; Parker, Ruth M. (1 June 2006). "Misunderstanding of prescription drug warning labels among patients with low literacy". American Journal of Health-System Pharmacy. 63 (11): 1048–1055. doi:10.2146/ajhp050469. PMID   16709891.